Oska Health
Avoiding the consequences of kidney disease.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor investor investor investor investor | €0.0 | round | |
N/A | Seed | ||
| Total Funding | 000k | ||
| EUR | 2009 | 2010 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Oska Health is a German healthcare technology company founded in 2022 by Niklas Best, Claudia Ehmke, and Dr. Malte Waldeck. The founders established the company based on their firsthand experience with the challenges of caring for individuals with chronic illnesses, aiming to provide continuous support beyond sporadic doctor visits. The leadership team combines extensive experience in the kidney care industry, digital product development, and healthcare management. Niklas Best previously served as Director of Digital Products at Fresenius Medical Care, Claudia Ehmke has over 20 years of experience in the London tech scene, and Dr. Malte Waldeck has a background at DaVita Kidney Care and Dmed Healthcare Group.
The company operates in the digital health market, focusing specifically on improving the lives of people with chronic kidney disease (CKD). Oska Health has developed a digital platform that integrates a medical device-approved app with health coaching and intelligent algorithms. This system provides personalized and evidence-based remote health coaching to help patients manage their condition, with the goal of reducing hospital stays and overall care costs. The service targets CKD patients at various stages, excluding those already on dialysis, and aims to help them implement medical therapy recommendations and adopt healthier habits.
Oska Health's business model involves contracting with health insurance companies, making the platform available to insured patients. The company generates revenue by providing this continuous care solution to health payers, who benefit from reduced long-term healthcare costs associated with better chronic disease management. In February 2023, the company secured €2.5 million in a seed funding round led by LBBW Venture Capital, with participation from investors including Calm/Storm Ventures and Hessen Kapital.
Keywords: chronic kidney disease, digital health, health coaching, remote patient monitoring, health-app, medtech, value-based care, patient engagement, care platform, behavioral science